首页> 外国专利> гуманизованные antibodies specific for alpha - энолазе and ways of application in tumour тарапии

гуманизованные antibodies specific for alpha - энолазе and ways of application in tumour тарапии

机译:对α-烯醇化酶特异的人源化抗体及其在肿瘤治疗中的应用方法

摘要

A humanized antibody, or a binding fragment thereof, wherein the humanized antibody binds human ENOl (GenBank: AAH50642.1), wherein the antibody comprises a light chain variable region (VL) domain comprising a CDR1 having the amino acid sequence LCDR1 (RASENIYSYLT; SEQ ID NO:6) and a CDR2 having the amino acid sequence LCDR2 (NAKTLPE; SEQ ID NO:7) and a CDR3 having the amino acid sequence LCDR3 (QHHYGTPYT; SEQ ID NO: 8) and an antibody heavy chain variable region (VH) domain comprising a CDR1 having the amino acid sequence HCDR1 (GYTFTSCVMN; SEQ ID NO:3), a CDR2 having the amino acid sequence HCDR2 (YINPYNDGTKYNEKFKG; SEQ ID NO:4) and a CDR3 having the amino acid sequence HCDR3 (EGFYYGNFDN; SEQ ID NO: 5), wherein framework regions in the light chain variable region (VL) domain and the heavy chain variable region (VH) domain comprise amino acid sequences from a human immunoglobulin.
机译:一种人源化抗体或其结合片段,其中所述人源化抗体结合人EN01(GenBank:AAH50642.1),其中所述抗体包含轻链可变区(VL)结构域,所述轻链可变区(VL)结构域包含具有氨基酸序列LCDR1(RASENIYSYLT; SEQ ID NO:6)和具有氨基酸序列LCDR2(NAKTLPE; SEQ ID NO:7)的CDR2和具有氨基酸序列LCDR3(QHHYGTPYT; SEQ ID NO:8)的CDR3和抗体重链可变区( VH)结构域,其包含具有氨基酸序列HCDR1(GYTFTSCVMN; SEQ ID NO:3)的CDR1,具有氨基酸序列HCDR2(YINPYNDGTKYNEKFKG; SEQ ID NO:4)的CDR2和具有氨基酸序列HCDR3(EGFYYGNFDN)的CDR3 ; SEQ ID NO:5),其中轻链可变区(VL)结构域和重链可变区(VH)结构域中的框架区包含来自人免疫球蛋白的氨基酸序列。

著录项

  • 公开/公告号RU2017123022A3

    专利类型

  • 公开/公告日2019-01-09

    原文格式PDF

  • 申请/专利权人

    申请/专利号RU20170123022

  • 发明设计人

    申请日0000-00-00

  • 分类号A61K39;

  • 国家 RU

  • 入库时间 2022-08-21 11:47:08

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号